1-[2,3-DIDEOXY-5-O-(TRIPHENYLMETHYL)-BETA-D-GLYCERO-PENTOFURANOSYL]-1H-PYRROLO-[2,3-B]-PYRIDINE
Compound with spectra: 1 NMR
![1-[2,3-DIDEOXY-5-O-(TRIPHENYLMETHYL)-BETA-D-GLYCERO-PENTOFURANOSYL]-1H-PYRROLO-[2,3-B]-PYRIDINE](/api/compound/8KhxAfCT3u5.png?ph=true&h=300&w=458 "1-[2,3-DIDEOXY-5-O-(TRIPHENYLMETHYL)-BETA-D-GLYCERO-PENTOFURANOSYL]-1H-PYRROLO-[2,3-B]-PYRIDINE")
| SpectraBase Compound ID | 8KhxAfCT3u5 |
|---|---|
| InChI | InChI=1S/C31H28N2O2/c1-4-12-25(13-5-1)31(26-14-6-2-7-15-26,27-16-8-3-9-17-27)34-23-28-18-19-29(35-28)33-22-20-24-11-10-21-32-30(24)33/h1-17,20-22,28-29H,18-19,23H2/t28-,29+/m1/s1 |
| InChIKey | KAWZHVBTCSHKKV-WDYNHAJCSA-N |
| Mol Weight | 460.58 g/mol |
| Molecular Formula | C31H28N2O2 |
| Exact Mass | 460.215078 g/mol |
| Enantiomer InChIKey | KAWZHVBTCSHKKV-URLMMPGGSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
4-AMINO-1-(2,3-DIDEOXY-ALPHA-D-GLYCERO-PENTOFURANOSYL)-1H-PYRROLO-[2,3-B]-PYRIDINE
4-AMINO-1-(2,3-DIDEOXY-BETA-D-GLYCERO-PENTOFURANOSYL)-1H-PYRROLO-[2,3-B]-PYRIDINE
4-CHLORO-7-(2,3-DIDEOXY-ALPHA-D-GLYCERO-PENTOFURANOSYL)-7H-PYRROLO-[2,3-D]-PYRIMIDINE
4-methyl-1-{4-methyl-5-[(triphenylmethoxy)methyl]oxolan-2-yl}-1,2-dihydropyrimidin-2-one
1-DEAZAPURINE-2'-DEOXYRIBONUCLEOSIDE;N9-ISOMER
3'-Deoxy-2'-keto-5'-O-trityluridine
1,2-Dideoxy-5-O-(4,4'-dimethoxytrityl)-3-O-(4-methoxybenzyl)-1-(3-pyridyl)-.alpha.-and .beta.-D-ribofuranose
Methyl 6-O-diphenyl(thiophenyl)methyl .alpha.,D-glucopyranoside
1,2-O-ISOPROPYLIDENE-6-O-TRITYL-ALPHA-D-GLUCOFURANOSE
(4S,5S)-5-phenyl-2-(2-thienyl)-4-(trityloxymethyl)-2-oxazoline
| Title | Journal or Book | Year |
|---|---|---|
| 1,7-Dideaza-2?,3?-dideoxyadenosine: Syntheses of Pyrrolo[2,3-b]pyndine 2?,3?-Dideoxyribofuranosides and Participation of Purine N(1) during HIV-1 Reverse Transcriptase Inhibition | Helvetica Chimica Acta | 1991 |